coronavirus

Expanding eligibility for COVID-19 boosters to include ages 12 and up is welcome news as the Omicron variant fuels a surge in cases around the country. 

Following approval by the Food and Drug Administration (FDA), the Centers for Disease Control and Prevention (CDC) has expanded its booster recommendation to include ages 12 to 15. The CDC previously expanded eligibility to ages 16 and 17 and is now recommending boosters for this group. 

On Tuesday evening, November 2, 2021, the Centers for Disease Control and Prevention (CDC) joined the U.S. Food and Drug Administration (FDA) in approval of the Pfizer (Comirnaty) vaccine for children ages 5 – 11 years old, at a lower dosage.

“Although COVID-19 may impact children less severely than adults, it is a serious illness and can lead to significant long-term effects on people of all ages,” said Coconino County Health and Human Services (CCHHS) Director Kim Musselman. “The approval of vaccinations for this younger age group is a critical step toward ending the pandemic.”

Federal officials are recommending that Arizonans 65 and older, residents of long-term care facilities, and those ages 50 to 64 with underlying medical condi

Nearly all cases, hospitalizations, and deaths are among the unvaccinated

Arizona today hit a new milestone in the war on COVID-19: more than 4 million men, women and children over 12 have now received at least one dose of the vaccine.

“Arizonans are stepping up and doing their part to put this pandemic behind us,” said Don Herrington, interim director of the Arizona Department of Health Services. “This battle is not over but we’re clearly headed in the right direction.”

If the term “emergency use authorization” has kept you from getting vaccinated against COVID-19, it’s time to join millions of Arizonans who protected themselves, their families, and their communities by getting a life-saving jab. 

The Centers for Disease Control and Prevention (CDC) recommends that certain immunocompromised individuals who have already received an initial two doses of mRNA COVID-19 vaccine (Pfizer-BioNTech or Moderna) receive an additional dose.

Emerging evidence shows some people who are moderately to severely immunocompromised experienced a reduced immune response to the initial COVID-19 vaccine series. The administration of an additional mRNA COVID-19 VACCINE aims to prevent serious and possibly life-threatening COVID-19 within this population.